Implementation of a multidisciplinary Enhanced Recovery After Surgery program for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

被引：0
|
作者：
Stockley, Cecily [1 ]
Bouchard-Fortier, Antoine [1 ]
Mateshaytis, Jennifer [2 ]
Nelson, Gregory [1 ]
Mack, Lloyd [1 ]
Chong, Michael [3 ]
Deban, Melina [1 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Univ Calgary, Dept Gynecol Oncol, Calgary, AB, Canada
[3] Univ Calgary, Anesthesiol, Foothills Med Ctr, Calgary, AB, Canada
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E352
引用
收藏
页码：S230 / S230
页数：1
相关论文
共 50 条
  • [41] Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy
    Cortes-Guiral, Delia
    Mohamed, Faheez
    Glehen, Olivier
    Passot, Guillaume
    EJSO, 2021, 47 (01): : 60 - 64
  • [42] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria
    Kogler Pamela
    Zitt Matthias
    Kafka-Ritsch Reinhold
    Punter Julia
    Müssigang Peter
    Perathoner Alexander
    Öfner Dietmar
    Journal of Gastrointestinal Surgery, 2018, 22 : 884 - 893
  • [43] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Nikolaos Vassos
    Thomas Förtsch
    Archil Aladashvili
    Werner Hohenberger
    Roland S. Croner
    World Journal of Surgical Oncology, 14
  • [44] Appendiceal Goblet Cell Carcinoma: Role of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    M. Gaillard
    P. Van Eyken
    G. Verswijvel
    K. Van der Speeten
    Indian Journal of Surgical Oncology, 2023, 14 : 240 - 249
  • [45] Factors affecting dietary progression post cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Stibbard, Allysha
    Brown, Morgan
    Pons, Rachel
    Ward, Jessica
    Page, Naomi
    Stefoska-Needham, Anita
    CLINICAL NUTRITION ESPEN, 2024, 63 : 520 - 529
  • [46] Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Chokshi, Ravi J.
    Kim, Jin K.
    Patel, Jimmy
    Oliver, Joseph B.
    Mahmoud, Omar
    PLEURA AND PERITONEUM, 2020, 5 (03)
  • [47] Impact of Successful Implementation of an Enhanced Recovery After Surgery Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Beatrice J. Sun
    Tiffany M. Yue
    Nova Xu
    Cedar Fowler
    Byrne Lee
    Annals of Surgical Oncology, 2023, 30 : 8156 - 8165
  • [48] Impact of Successful Implementation of an Enhanced Recovery After Surgery Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Sun, Beatrice J.
    Yue, Tiffany M.
    Xu, Nova
    Fowler, Cedar
    Lee, Byrne
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (13) : 8156 - 8165
  • [49] Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Elderly
    Votanopoulos, K. I.
    Shen, P.
    Stewart, J. H.
    Russell, G.
    Levine, E. A.
    Newman, N. A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S100 - S101
  • [50] Outcome of Icelandic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) abroad
    Petursdottir, Astriour
    Gunnarsson, Orvar
    Valsdottir, Elsa B.
    LAEKNABLADID, 2020, 106 (7-8): : 344 - 348
12345